Professional CDMO for high-quality generic drugs

Huayi Pharmaceutical (Anhui) Co. Ltd. is an EU cGMP approved Sino-British joint venture located in Hefei, Eastern China. We manufacture quality generic medicines on a contractual basis for EU and Chinese customers with competitive pricing. We offer a one-stop integrated service for our customers including pharmaceutical development, contract manufacture and bioequivalence studies.

Huayi values excellent communication with our partners. We are confident in our ability to work with customers from all countries from our facilities in China. Partner with us for your next project and experience our customer-focused service, quality manufacturing and integrated services.

About Huayi Pharma

We manufacture solid oral dosage forms for customers in Europe and are adding liquid forms in 2020. We offer competitive prices without compromising on our high quality standards. Huayi also offers an integrated formulation development service including R&D, originator profile matching, method development, stability studies as well as contract manufacture.

About Us


The Latest Insights from Huayi

Research & Development

We are experienced in technology transfers and scale-up process for commercial production. Having transferred over 50 products for our customers and registering almost 100 strengths to date, we are prepared to take on new challenges in pharmaceutical development with our experienced team from Huayi China-Europe Pharmaceutical Research Institute.

Read More

01 / 04

Quality Management

Huayi’s QA team is committed to ensuring your project adheres to EU cGMP standards at every step of production from development to commercial manufacture. We will work hard to ensure that your project will be completed on time to the highest quality and stay focused and communicative throughout the process.

Read More

02 / 04

Contract Manufacturing

In 2018, our contract manufacturing output reached 1.6 billion units. Huayi manufactures solid oral dosage forms including film-coated, sugar-coated, enteric-coated, effervescent, soluble, chewable and buccal tablets as well as capsules. Our high-potency and liquid preparation facilities will be ready in 2020.

Read More

03 / 04

Integrated Services

We offer bioequivalence studies for your next project in China. Through our partners Weida Clinical Research and Velocyte Analytical Technology, we can conduct clinical trials, biological sample testing, dissolution profiling and stability studies. We can then scale-up from the test batch to commercial production.

Read More

04 / 04